Voyager Therapeutics, Inc. (VYGR) earnings
VYGR earnings moved a median of +0.93% by the close. Quarterly and annual VYGR reports and results, each read against the price at its own news timestamp. Back to the VYGR overview →
27 measured VYGR earnings events.
Where these VYGR earnings landedvs 27 measured VYGR earnings reactions
| Middle 50% of VYGR earnings reactions | -3.05% to +3.32% |
|---|---|
| Median reaction (to close) | +0.93% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 VYGR earnings events with a measured close landed between -3.05% and +3.32%; 67% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Voyager Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.47% | +6.51% | |
| Voyager Reports Second Quarter 2026 Financial and Operating Results | Press release | +1.47% | +6.51% | |
| Form 10-Q Voyager Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +3.32% | |
| Voyager Reports First Quarter 2026 Financial and Operating Results | Press release | +0.00% | +3.32% | |
| Form 10-K Voyager Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +21.66% | |
| Form 10-Q Voyager Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.42% | +0.71% | |
| Voyager Reports Third Quarter 2025 Financial and Operating Results | Press release | +1.42% | +0.71% | |
| Form 10-Q Voyager Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.72% | -5.29% | |
| Voyager Reports Second Quarter 2025 Financial and Operating Results | Press release | +0.72% | -5.29% | |
| Form 10-Q Voyager Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.93% | +1.24% | |
| Voyager Reports First Quarter 2025 Financial and Operating Results | Press release | +0.93% | +1.24% | |
| Form 10-K Voyager Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -3.68% | +6.84% | |
| Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast | Press release | -0.52% | +2.06% | |
| Form 10-Q Voyager Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.14% | -4.70% | |
| Voyager Reports Third Quarter 2024 Financial and Operating Results | Press release | +0.14% | -4.70% | |
| Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast | Press release | +0.15% | +1.68% | |
| Form 10-Q Voyager Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.28% | -17.47% | |
| Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results | Press release | -3.28% | -17.47% | |
| Voyager Therapeutics Announces Second Quarter 2024 Conference Call and Webcast | Press release | +0.54% | +0.76% | |
| Form 10-Q Voyager Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.29% | -1.40% | |
| Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results | Press release | +0.29% | -1.40% | |
| Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast | Press release | +0.17% | +0.45% | |
| Form 10-K Voyager Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -5.53% | -16.38% | |
| Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast | Press release | -0.13% | +0.93% | |
| Form 10-Q Voyager Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +3.93% | +7.23% | |
| Voyager Therapeutics Reports Third Quarter 2023 Financial and Operating Results | Press release | +3.93% | +7.23% | |
| Voyager Therapeutics Announces Third Quarter 2023 Conference Call and Webcast | Press release | -0.08% | +0.93% |
Keep exploring
More VYGR: analyst actions → · SEC filings → · VYGR overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Wave Life Sciences, Inc. (WVE) | 321 | -0.14% | 45% |
| Pulse Biosciences, Inc (PLSE) | 320 | +0.18% | 55% |
| Viking Therapeutics, Inc. (VKTX) | 319 | -0.60% | 43% |
| Aptevo Therapeutics Inc. (APVO) | 318 | -0.89% | 34% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.